Preparation and biocompatibility of a novel strontium-containing calcium sulfate.
- Author:
	        		
		        		
		        		
			        		Yi-Long HOU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Xue LI
			        		
			        		;
		        		
		        		
		        		
			        		Chang-Peng XU
			        		
			        		;
		        		
		        		
		        		
			        		Jin-Qi SONG
			        		
			        		;
		        		
		        		
		        		
			        		Lei HUANG
			        		
			        		;
		        		
		        		
		        		
			        		Bin YU
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Animals; Biocompatible Materials; chemistry; Bone Substitutes; chemistry; Calcium Sulfate; chemistry; Cell Line; Mice; Microscopy, Electron, Scanning; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Strontium; chemistry; X-Ray Diffraction
 - From: Journal of Southern Medical University 2016;36(7):947-951
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo prepare a novel strontium-containing calcium sulfate and assess its and biocompatibility.
METHODSA novel strontium-containing α-calcium sulfate hemihydrate (Sr-caS) bone substitute as prepared with hydrothermal reaction and examined for X-ray diffraction (XRD), Fourier transform infrared (FTIR) and thermogravimetric differential scanning calorimetric (TG-DSC) patterns. The biocompatibility of the material was evaluated by in vitro cytotoxicity test in L-929 cells, hemolysis test of blood, and in vivo implantation test in SD rats.
RESULTSThe XRD spectra of the prepared Sr-CaS powder highlighted 3 strong characteristic peaks of α-CaSO4 at 14.63°, 25.72° and 29.80° with a strontium-specific peak at 24.78°. The FTIR patterns of Sr-CaS resembled those of CaS. TG-DSC results showed that the material contained a non-evaporable water content of 6.03%. In vitro cytotoxicity test in L-929 cells suggested that the material had a class 1 cytotoxicity, and the hemolysis rate of its aqueous extract was 4.3%. The material implanted in the muscular tissues of SD rats maintained a steady state in the surrounding tissues.
CONCLUSIONThis strontium-containing calcium sulfate material we prepared shows an excellent biocompatibility for potential use as a novel artificial bone material.
 
            